or Try an Advanced Search...

    Pre Clinical Development Stocks List

    Symbol Grade Name % Change
    SDGR C Schrodinger, Inc. 6.26
    CRL D Charles River Laboratories International, Inc. 3.35
    View As Page of Charts
    Related Industries: Diagnostics & Research Health Information Services
    Related Stock Lists: Drug Discovery Biotechnology Clinical Services Contract Research Organizations Detection Products Diagnostic Services Drug Metabolism In Vitro Lab Testing Laboratory Services Life Sciences Materials Science Metabolism Pathology Pathology Services Pharmaceutical Pharmacokinetics S&P 500 Simulation Software Toxicology

    Related ETFs - A few ETFs which own one or more of the above listed Pre Clinical Development stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 4.14
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 2.47
    HELX D Franklin Genomic Advancements ETF 2.23
    BBH D Market Vectors Biotech ETF 2.01
    LRNZ A TrueMark Technology, AI & Deep Learning ETF 1.98
    View all Pre Clinical Development ETFs...
    Compare ETFs
    Compare ARKG to FTXH Compare BBH to LRNZ Compare FTXH to HELX

        Pre Clinical Development Stocks Recent News

        Date Stock Title
        Nov 21 SDGR Schrödinger: Positive Signs Despite The Share Price Decline
        Nov 20 SDGR Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
        Nov 19 CRL Charles River Laboratories: Not The Right Time To Own At This Point In The Cycle
        Nov 18 SDGR Schrödinger Broadens and Accelerates Predictive Toxicology Initiative
        Related Industries: Diagnostics & Research Health Information Services
        Related Stock Lists: Drug Discovery Biotechnology Clinical Services Contract Research Organizations Detection Products Diagnostic Services Drug Metabolism In Vitro Lab Testing Laboratory Services Life Sciences Materials Science Metabolism Pathology Pathology Services Pharmaceutical Pharmacokinetics S&P 500 Simulation Software Toxicology
        Pre Clinical Development

        Preclinical development is the stage of drug development that occurs before clinical trials begin. During this stage, researchers test the safety and efficacy of a drug in laboratory and animal studies. The goal of preclinical development is to determine if a drug is safe and effective enough to be tested in humans. Preclinical development also helps researchers understand how the drug works in the body and how it is metabolized.

        Browse All Tags